RadNet, Inc. 10-Q Summary: Quarter Ended September 30, 2025
Business Context and Reporting Period
RadNet, Inc. is a national provider of freestanding, fixed-site outpatient diagnostic imaging services operating 407 centers across eight U.S. states. The company reports two segments: Imaging Centers and Digital Health. This filing covers the quarterly period ended September 30, 2025, and the nine months ended September 30, 2025. The company operates a significant portion of its centers through joint ventures with hospitals and health systems.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Total Service Revenue | $522.9M | $461.1M | $1,492.5M | $1,352.6M |
| Operating Income | $27.4M | $33.9M | $34.2M | $80.1M |
| Net Income (Consolidated) | $13.9M | $12.3M | $7.2M | $24.6M |
| Net Income (Attributable to RadNet) | $5.4M | $3.2M | $(18.1M) | $(2.6M) |
| Diluted EPS (Attributable to RadNet) | $0.07 | $0.04 | $(0.24) | $(0.04) |
| Operating Cash Flow (9M) | $214.7M (vs. $190.5M prior year) | |||
| Cash and Equivalents | $804.7M (as of Sept 30, 2025) | |||
| Total Debt Obligations | $1,096.3M (as of Sept 30, 2025) | |||
| Adjusted EBITDA (Total) | $84.9M | $73.7M | $212.5M | $204.5M |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 13.4% year-over-year in Q3 and 10.3% for the nine-month period. Same-center revenue grew 9.6% in Q3, driven by a 4.4% increase in procedure volume and higher fees per procedure. Advanced imaging (MRI, CT, PET/CT) volumes rose significantly.
- Operating Expenses: Operating expenses increased 13.1% in Q3. Key drivers included a 11.7% rise in salaries and professional fees due to wage inflation and staffing increases, and a 12.7% increase in medical supplies driven by higher utilization of isotope tracers for PET/CT.
- One-Time Charges: The company recognized $2.8M in lease abandonment charges in Q3 and $8.3M for the nine months, related to closing low-utilization centers. Stock-based compensation increased 61.4% in Q3 to $6.8M.
- Digital Health Segment: Revenue grew 51.6% in Q3 to $24.8M, largely due to the acquisition of iCAD, Inc. However, the segment reported an operating loss of $9.9M for the quarter and $23.1M for the nine months, contributing to the consolidated net loss attributable to common stockholders for the nine-month period.
- Interest Expense: Interest expense decreased 10.7% in Q3 and 16.2% for the nine months, primarily due to the repricing of the Barclays Credit Facility in late 2024, partially offset by new incremental term loan borrowings.
Guidance, Outlook, and Risks
- Acquisitions: RadNet completed the acquisition of iCAD, Inc. (AI breast health solutions) for approximately $110.7M in stock and See-Mode Technologies (AI ultrasound) for $28.7M. These acquisitions are being integrated into the Digital Health segment.
- Capital Structure: In June 2025, the company secured an additional $100M incremental term loan under its Barclays facility. As of September 30, 2025, the company had $275M available under its Barclays revolver and $50M under its Truist revolver.
- Outlook: Management expects the Digital Health segment to continue operating at a net loss in the near term as integration progresses. The company anticipates sustained growth in advanced imaging procedures and the rollout of AI-powered diagnostic solutions.
- Risks: Key risks include foreign currency exchange exposure (UK, Netherlands, Canada, Hungary, India), interest rate sensitivity on variable-rate debt, and the ability to successfully integrate acquired businesses. The company noted no material impairment of goodwill or intangible assets as of September 30, 2025.
Investor Verification Checklist
- Noncontrolling Interest Impact: Verify the impact of noncontrolling interests ($8.5M in Q3, $25.2M in 9M) on net income attributable to RadNet common stockholders, which resulted in a GAAP loss for the nine-month period despite positive consolidated net income.
- Digital Health Losses: Assess the timeline for the Digital Health segment to reach profitability following the iCAD and See-Mode acquisitions, given the $23.1M operating loss for the nine months.
- Debt Covenants: Confirm continued compliance with financial covenants under the Barclays and Truist credit facilities, particularly given the increased debt load from the $100M incremental term loan.
- Lease Abandonment: Monitor future lease abandonment charges as the company continues to optimize its center footprint and close low-utilization facilities.
- Interest Rate Swaps: Review the maturity of the 2019 interest rate swaps (October 2025) and the company's strategy for managing interest rate exposure on the remaining unprotected debt ($563.6M).